Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Residual macrovascular risk in 2013: what have we learned?
Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM Jr, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés JM, Monfil CC, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P; Residual Risk Reduction Initiative (R3i). Fruchart JC, et al. Cardiovasc Diabetol. 2014 Jan 24;13:26. doi: 10.1186/1475-2840-13-26. Cardiovasc Diabetol. 2014. PMID: 24460800 Free PMC article. Review.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P. Fruchart JC, et al. Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Cardiovasc Diabetol. 2019. PMID: 31164165 Free PMC article. Review.
[Introduction. Justification].
Núñez-Cortés JM. Núñez-Cortés JM. Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:1-2. doi: 10.1016/S0214-9168(14)70017-8. Clin Investig Arterioscler. 2014. PMID: 25043538 Spanish. No abstract available.
[Reasons for a combination].
Núñez-Cortés JM. Núñez-Cortés JM. Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:40-1. doi: 10.1016/S0214-9168(14)70026-9. Clin Investig Arterioscler. 2014. PMID: 25043547 Spanish. No abstract available.
[Presentation].
Núñez-Cortés JM. Núñez-Cortés JM. Clin Investig Arterioscler. 2016 Jul;28 Suppl 3:1-2. doi: 10.1016/S0214-9168(16)30082-1. Clin Investig Arterioscler. 2016. PMID: 27473464 Spanish. No abstract available.
Atherogenic dyslipemia: the other pandemic, associated with diabesity.
Núñez-Cortés JM, Pedro-Botet J. Núñez-Cortés JM, et al. Clin Investig Arterioscler. 2021 Jan-Feb;33(1):30-32. doi: 10.1016/j.arteri.2020.12.001. Clin Investig Arterioscler. 2021. PMID: 33455724 Free PMC article. English, Spanish. No abstract available.
[The importance of vascular risk in type 2 diabetes mellitus].
Pedro-Botet J, Núñez-Cortés JM. Pedro-Botet J, et al. Clin Investig Arterioscler. 2014 May-Jun;26(3):138-9. doi: 10.1016/j.arteri.2014.05.001. Clin Investig Arterioscler. 2014. PMID: 24939690 Spanish. No abstract available.
32 results